Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22.3M
-
Number of holders
-
167
-
Total 13F shares, excl. options
-
12.3M
-
Shares change
-
+1.94M
-
Total reported value, excl. options
-
$661M
-
Value change
-
+$105M
-
Put/Call ratio
-
0.92
-
Number of buys
-
115
-
Number of sells
-
-36
-
Price
-
$53.83
Significant Holders of ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) as of Q2 2023
183 filings reported holding ANIP - ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share as of Q2 2023.
ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) has 167 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.3M shares
of 22.3M outstanding shares and own 55.13% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2.13M shares), VANGUARD GROUP INC (1.07M shares), Rubric Capital Management LP (847K shares), DIMENSIONAL FUND ADVISORS LP (544K shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (539K shares), Deep Track Capital, LP (514K shares), STATE STREET CORP (486K shares), Global Alpha Capital Management Ltd. (453K shares), Ranger Investment Management, L.P. (445K shares), and THOMPSON SIEGEL & WALMSLEY LLC (362K shares).
This table shows the top 167 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.